Literature DB >> 27043703

Reversible cerebral vasoconstriction syndromes and primary angiitis of the central nervous system: clinical, imaging, and angiographic comparison.

Aneesh B Singhal1, Mehmet A Topcuoglu1,2, Joshua W Fok3, Oguzhan Kursun4, Raul G Nogueira5, Matthew P Frosch1, Verne S Caviness1.   

Abstract

Reversible cerebral vasoconstriction syndromes (RCVS) and primary angiitis of the central nervous system (PACNS) are invariably considered in the differential diagnosis of new cerebral arteriopathies. However, prompt and accurate diagnosis remains challenging. Here we compared the features of 159 RCVS to 47 PACNS patients and developed criteria for prompt bedside diagnosis. Recurrent thunderclap headache (TCH), and single TCH combined with either normal neuroimaging, border zone infarcts, or vasogenic edema, have 100% positive predictive value for diagnosing RCVS or RCVS-spectrum disorders. In patients without TCH and positive angiography, neuroimaging can discriminate RCVS (no lesion) from PACNS (deep/brainstem infarcts). Ann Neurol 2016;79:882-894.
© 2016 American Neurological Association.

Entities:  

Mesh:

Year:  2016        PMID: 27043703     DOI: 10.1002/ana.24652

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  37 in total

1.  Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Ospel; C H Wright; R Jung; L L M Vidal; S Manjila; G Singh; D V Heck; A Ray; K A Blackham
Journal:  AJNR Am J Neuroradiol       Date:  2019-12-26       Impact factor: 3.825

2.  Severe reversible cerebral vasoconstriction syndrome after taking a product for slimming.

Authors:  Carlo Piantadosi; Loredana Bove; Marco Minnetti; Mauro Brogi
Journal:  Neurol Sci       Date:  2016-08-01       Impact factor: 3.307

3.  Diagnostic Impact of Intracranial Vessel Wall MRI in 205 Patients with Ischemic Stroke or TIA.

Authors:  J D Schaafsma; S Rawal; J M Coutinho; J Rasheedi; D J Mikulis; C Jaigobin; F L Silver; D M Mandell
Journal:  AJNR Am J Neuroradiol       Date:  2019-09-05       Impact factor: 3.825

4.  A unique case of cabergoline-induced reversible cerebral vasoconstriction.

Authors:  Orly Moshe-Lilie; Parker Miller; Michael Lane
Journal:  Neurol Clin Pract       Date:  2019-12

5.  Quantifying Intra-Arterial Verapamil Response as a Diagnostic Tool for Reversible Cerebral Vasoconstriction Syndrome.

Authors:  J M Sequeiros; J A Roa; R P Sabotin; S Dandapat; S Ortega-Gutierrez; E C Leira; C P Derdeyn; G Bathla; D M Hasan; E A Samaniego
Journal:  AJNR Am J Neuroradiol       Date:  2020-09-17       Impact factor: 3.825

6.  Hemorrhagic primary CNS angiitis and vasoconstrictive drug exposure.

Authors:  Mehmet A Topcuoglu; Ruchira M Jha; Jacob George; Matthew P Frosch; Aneesh B Singhal
Journal:  Neurol Clin Pract       Date:  2017-02

Review 7.  Vessel Wall Imaging of Cerebrovascular Disorders.

Authors:  Kyle C Kern; David S Liebeskind
Journal:  Curr Treat Options Cardiovasc Med       Date:  2019-11-14

Review 8.  Preeclampsia and Cerebrovascular Disease.

Authors:  Eliza C Miller
Journal:  Hypertension       Date:  2019-05-06       Impact factor: 10.190

9.  Cerebrospinal fluid findings in reversible cerebral vasoconstriction syndrome: a way to differentiate from cerebral vasculitis?

Authors:  L Kraayvanger; P Berlit; P Albrecht; H-P Hartung; M Kraemer
Journal:  Clin Exp Immunol       Date:  2018-07-23       Impact factor: 4.330

10.  Glucocorticoid-associated worsening in reversible cerebral vasoconstriction syndrome.

Authors:  Aneesh B Singhal; Mehmet A Topcuoglu
Journal:  Neurology       Date:  2016-12-09       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.